ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

63 hedge funds and large institutions have $151M invested in Adamas Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$6.11M
2 -$302K
3 -$216K
4
Goldman Sachs
Goldman Sachs
New York
-$201K
5
Morgan Stanley
Morgan Stanley
New York
-$186K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$740K
27
$682K
28
$674K
29
$626K
30
$597K
31
$551K
32
$529K
33
$521K
34
$484K
35
$338K
36
$333K
37
$285K
38
$262K
39
$229K
40
$224K
41
$192K
42
$166K
43
$165K
44
$150K
45
$103K
46
$94K
47
$72K
48
$65K
49
$49K
50
$38K